Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 2
2016 2
2017 3
2018 2
2019 2
2020 1
2021 5
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Cannabinoids as potential treatment for neurological diseases.
Gómez-Cañas M, Morales P, Satta V, Rodríguez-Cueto C, García C, Sagredo O. Gómez-Cañas M, et al. Among authors: rodriguez cueto c. Front Neurosci. 2022 Dec 20;16:1108101. doi: 10.3389/fnins.2022.1108101. eCollection 2022. Front Neurosci. 2022. PMID: 36605545 Free PMC article. No abstract available.
Endocannabinoid-Binding Receptors as Drug Targets.
Gómez-Cañas M, Rodríguez-Cueto C, Satta V, Hernández-Fisac I, Navarro E, Fernández-Ruiz J. Gómez-Cañas M, et al. Among authors: rodriguez cueto c. Methods Mol Biol. 2023;2576:67-94. doi: 10.1007/978-1-0716-2728-0_6. Methods Mol Biol. 2023. PMID: 36152178
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice.
Santos-García I, Rodríguez-Cueto C, Villegas P, Piscitelli F, Lauritano A, Shen CJ, Di Marzo V, Fernández-Ruiz J, de Lago E. Santos-García I, et al. Among authors: rodriguez cueto c. J Neuroinflammation. 2023 May 6;20(1):108. doi: 10.1186/s12974-023-02792-z. J Neuroinflammation. 2023. PMID: 37149645 Free PMC article.
Prospects for cannabinoid therapies in basal ganglia disorders.
Fernández-Ruiz J, Moreno-Martet M, Rodríguez-Cueto C, Palomo-Garo C, Gómez-Cañas M, Valdeolivas S, Guaza C, Romero J, Guzmán M, Mechoulam R, Ramos JA. Fernández-Ruiz J, et al. Among authors: rodriguez cueto c. Br J Pharmacol. 2011 Aug;163(7):1365-78. doi: 10.1111/j.1476-5381.2011.01365.x. Br J Pharmacol. 2011. PMID: 21545415 Free PMC article. Review.
Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets.
Gómez-Ruiz M, Rodríguez-Cueto C, Luna-Piñel E, Hernández-Gálvez M, Fernández-Ruiz J. Gómez-Ruiz M, et al. Among authors: rodriguez cueto c. Front Mol Neurosci. 2019 Apr 24;12:94. doi: 10.3389/fnmol.2019.00094. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31068788 Free PMC article. Review.
21 results